Prostate Cancer Coverage From Every Angle
Editor:
James L. Mohler, MD
Advertisement
Advertisement

Published Medical Literature

Does Apalutamide Negatively Impact Quality of Life in Nonmetastatic CRPC?
AUA Guideline Amendment for Castration-Resistant Prostate Cancer
Closer Look at Types of Prostatectomy and Quality of Life
Does Androgen-Deprivation Therapy Increase Risk of Heart Failure in Men With Prostate Cancer?
Can Tyrosine Kinase Inhibitors for CML Affect PSA Titers Unrelated to Prostatic Disease?
Assessing Combination of Osteoprotective Agents and Anticancer Drugs in Prostate Cancer
Early Research on Birabresib in Prostate Cancer and Other Solid Tumors
Noninvasive Diagnosis of Prostate Cancer Using Novel Imaging Technique
Long-Term Results With Hormonal Therapy Plus Radiotherapy in Prostate Cancer
Active Surveillance for Prostate Cancer: Are Patients Being Lost to Follow-up?
PSA Screening for Prostate Cancer: Does It Really Reduce Disease-Specific Mortality?
Coffee Consumption and Disease-Free Progression in Patients With Localized Prostate Cancer
Are Researchers Closer to Diagnosing Aggressive Prostate Cancer at an Early Stage?
Rebiopsy for Prostate Cancer: Can Some Men With Negative MRI Avoid It?
Does Enzalutamide Affect Metastasis-Free Survival in Men With Aggressive Prostate Cancer?
Can Hypofractionated Radiotherapy Improve Prostate Cancer Control?
Low Free Testosterone Concentration May Equal Low Prostate Cancer Risk
Survival Impact of Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Does Surgical Technique Affect Outcomes in Patients With Prostate Cancer?
New Prognostic Imaging Biomarker in Metastatic Prostate Cancer
Report Sheds Light on Trends in Prostate Cancer
Pharmacoeconomic Implications of Low-Dose Abiraterone in Castration-Resistant Prostate Cancer
Predictors of Urinary Function After Prostatectomy
Updated USPSTF Screening Guidelines for Prostate Cancer
Timing of Catheter Removal After Robot-Assisted Radical Prostatectomy
Clinical Associations of Luminal and Basal Subtyping in Prostate Cancer
ASCO Clinical Practice Guidelines for Metastatic Noncastrate Prostate Cancer
Robot-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer
Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer
After Disease Progression on Enzalutamide, Can Bipolar Androgen Therapy Make a Difference in Prostate Cancer?
SPARTAN Trial: Apalutamide in Nonmetastatic Prostate Cancer
Radiotherapy Versus Surgery for High-Risk Localized Prostate Cancer
Health-Related Quality of Life After Radical Prostatectomy
Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.